Nestmedic S.A. (WSE:NST)

Market Cap	26.30M +41.5%
Revenue (ttm)	1.05M +57.3%
Net Income	-4.71M
EPS	-0.14
Shares Out	43.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,904
Average Volume	16,237
Open	0.6250
Previous Close	0.6200
Day's Range	0.5950 - 0.6300
52-Week Range	0.3900 - 1.0800
Beta	0.19
RSI	44.28
Earnings Date	May 13, 2026

About Nestmedic

Nestmedic S.A., together with its subsidiaries, manufactures, distributes, and sells telemedicine solutions under the Pregnabit brand. It offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. The company also provides Pregnabit Cloud, a software as a service system designed to work with tele...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Employees: 3
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: NST

Financial Performance

In 2024, Nestmedic's revenue was 969,196, a decrease of -37.39% compared to the previous year's 1.55 million. Losses were -5.38 million, -20.53% less than in 2023.